The scientist behind the online cartoon RedPen/BlackPen explains how humor can build bridges between scientists and the public.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Improving predictability of water quality and nutrient cycling in large river systems.

Developing conceptual models for microbial-environmental–ecosystem interactions is key to enhancing the ability of models to predict future ecosystem function.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

PNNL’s Scott Baker has been elected a fellow by the American Association for the Advancement of Science.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

Research from the PNNL-led WHONDRS consortium reveals chemistry and spatial gradients of metabolomes from river water and sediments around the globe.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.

In adjoining Energy Sciences Center laboratories, researchers develop better energy storage devices by understanding the fundamental reactions that form interfaces.

From water purification, to better batteries and tools to foil a cyberattack—a look back at how PNNL helped to invent a brighter and better future over the last year.

A multi-institutional team has developed a deep learning framework to identify novel molecules as drug candidates.

A multi-institutional team has obtained information about nanoscale interactions between the spike protein of the novel coronavirus SARS-CoV-2 and common household inorganic surfaces.

Scientists have devised a way to engineer yeast to produce sustainable, eco-friendly commodity chemicals using computing power as a guide.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

Customized molecular tools identify specific microbial functions that are key to healthy people and environments.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Developed at PNNL, Shear Assisted Processing and Extrusion, or ShAPE™, uses significantly less energy and can deliver components like wire, tubes and bars 10 times faster than conventional extrusion, with no sacrifice in quality.